These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104 [TBL] [Abstract][Full Text] [Related]
3. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
4. Fatty acids isolated from Toxoplasma gondii reduce glycosylphosphatidylinositol-induced tumor necrosis factor alpha production through inhibition of the NF-kappaB signaling pathway. Debierre-Grockiego F; Rabi K; Schmidt J; Geyer H; Geyer R; Schwarz RT Infect Immun; 2007 Jun; 75(6):2886-93. PubMed ID: 17387164 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Lüder CG; Lang T; Beuerle B; Gross U Clin Exp Immunol; 1998 May; 112(2):308-16. PubMed ID: 9649196 [TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii glycosylphosphatidylinositols are not involved in T. gondii-induced host cell survival. Debierre-Grockiego F; Hippe D; Schwarz RT; Lüder CG Apoptosis; 2007 Apr; 12(4):781-90. PubMed ID: 17252196 [TBL] [Abstract][Full Text] [Related]
7. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression. Lang C; Algner M; Beinert N; Gross U; Lüder CG Microbes Infect; 2006 Jul; 8(8):1994-2005. PubMed ID: 16824778 [TBL] [Abstract][Full Text] [Related]
8. Secreted Toxoplasma gondii molecules interfere with expression of MHC-II in interferon gamma-activated macrophages. Leroux LP; Dasanayake D; Rommereim LM; Fox BA; Bzik DJ; Jardim A; Dzierszinski FS Int J Parasitol; 2015 Apr; 45(5):319-32. PubMed ID: 25720921 [TBL] [Abstract][Full Text] [Related]
9. Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice. Schlüter D; Deckert-Schlüter M; Schwendemann G; Brunner H; Hof H Immunology; 1993 Mar; 78(3):430-5. PubMed ID: 8478025 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes. Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349 [TBL] [Abstract][Full Text] [Related]
11. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. Buzoni-Gatel D; Lepage AC; Dimier-Poisson IH; Bout DT; Kasper LH J Immunol; 1997 Jun; 158(12):5883-9. PubMed ID: 9190941 [TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii grown in human cells uses GalNAc-containing glycosylphosphatidylinositol precursors to anchor surface antigens while the immunogenic Glc-GalNAc-containing precursors remain free at the parasite cell surface. Azzouz N; Shams-Eldin H; Niehus S; Debierre-Grockiego F; Bieker U; Schmidt J; Mercier C; Delauw MF; Dubremetz JF; Smith TK; Schwarz RT Int J Biochem Cell Biol; 2006; 38(11):1914-25. PubMed ID: 16822699 [TBL] [Abstract][Full Text] [Related]
13. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection. Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor MS-275 augments expression of a subset of IFN-γ-regulated genes in Toxoplasma gondii-infected macrophages but does not improve parasite control. Sumpf K; Nast R; Downie B; Salinas G; Lüder CGK Exp Parasitol; 2017 Sep; 180():45-54. PubMed ID: 28189488 [TBL] [Abstract][Full Text] [Related]
15. Roles of glycosylphosphatidylinositols of Toxoplasma gondii. Induction of tumor necrosis factor-alpha production in macrophages. Debierre-Grockiego F; Azzouz N; Schmidt J; Dubremetz JF; Geyer H; Geyer R; Weingart R; Schmidt RR; Schwarz RT J Biol Chem; 2003 Aug; 278(35):32987-93. PubMed ID: 12815041 [TBL] [Abstract][Full Text] [Related]
16. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388 [TBL] [Abstract][Full Text] [Related]
17. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116 [TBL] [Abstract][Full Text] [Related]
18. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1. Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643 [TBL] [Abstract][Full Text] [Related]